7 Stocks That Don’t Care Who Wins the Election

Posted on Friday, August 14th, 2020 by MarketBeat Staff
7 Stocks That Don’t Care Who Wins the ElectionMany investors confuse volatility in an election year with the market performance during an election year. Historically, investors don’t care all that much who wins the election.

Historical evidence shows that the market will rise after a Republican wins and dip after a Democrat wins. But that same evidence suggests that those trends flip in the first year of a presidency. It just proves that there’s a difference between campaigning and governing.

What can be different is where investors choose to make their money. Certain sectors perform better under a Republican administration than a Democrat administration. But that’s not the focus of this presentation.

Rather, we’re taking a look at companies and stocks that should profit no matter who occupies 1600 Pennsylvania Avenue. Some of these will be familiar names, but we’re trying not to be too obvious. Amazon (NASDAQ:AMZN) is a buy no matter who wins. You don’t need an article to tell you that.

And while I wouldn’t call this a list of “coronavirus stocks,” the list has some resemblance. The fact is every major event in our nation’s history has a ripple effect. And technologies that we never imagined would become “a thing” become the most important thing in our lives.

#1 - Shopify (NYSE:SHOP)

Shopify logo

The first company I want to look at is Shopify (NYSE:SHOP). Yes, I said I wasn’t going to be obvious with a name like Amazon, but e-commerce is a trend that’s too big to ignore and will continue into 2021 and beyond. Shopify is well-positioned to grab market share.

Shopify has managed to carve out a niche for itself as an e-commerce platform for small to midsize retailers who may feel underserved by Amazon. The company provides all the tools businesses need to set up and run an online store.

And investors will appreciate the growth. Since the company’s initial public offering (IPO) in 2015, SHOP stock has climbed over 4,000%. Recent partnerships with Pinterest (NYSE:PINS), Walmart (NYSE:WMT) and Chipotle Mexican Grill (NYSE:CMG) will add to the company’s growth.

The Covid-19 pandemic has underscored the importance of an e-commerce presence. This makes it highly likely that Shopify will continue to add customers as retailers understand that an online presence is now a matter of survival.

About Shopify
Shopify Inc, a commerce company, provides a commerce platform and services in Canada, the United States, the United Kingdom, Australia, Latin America, and internationally. The company's platform provides merchants to run their business in various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, and access financing.Read More 

Current Price: $1,525.00
Consensus Rating: Buy
Ratings Breakdown: 20 Buy Ratings, 12 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $1,593.78 (4.5% Upside)

#2 - PayPal (NASDAQ:PYPL)

PayPal logo

During the pandemic more businesses and consumers turned to digital payment processors like PayPal (NASDAQ:PYPL) to conduct business. This is honestly one of the big bank’s worst nightmares because for those who use PayPal, it’s becoming a lot closer to a full-service bank than some may realize. Technology is catching up, but PayPal is managing thus far to stay one step ahead.

One way the company is doing this can be seen its acquisition of the shopping and awards platform, Honey. The $4 billion acquisition was PayPal’s largest ever, but it looks to pay off in a key way. For the first time, PayPal can be part of the customer’s complete purchase journey instead of being simply the way to pay for it at checkout. 

PayPal may be an ideal stock to own if we are indeed moving closer to a cashless society. When PayPal reported earnings in May, the company said their user base was up over 20% on a year-over-year basis.

About PayPal
PayPal Holdings, Inc engages in the development of technology platform for digital payments. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm manages a two-sided proprietary global technology platform that links customers, which consist of both merchants and consumers, to facilitate the processing of payment transactions.Read More 

Current Price: $283.17
Consensus Rating: Buy
Ratings Breakdown: 33 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $311.38 (10.0% Upside)

#3 - Microsoft (NASDAQ:MSFT)

Microsoft logo

I’m allowing myself one big name here, but Microsoft (NASDAQ:MSFT) has two catalysts that are too big to ignore. First, the pandemic has led to the adoption of Microsoft Teams. This is an alternative to Slack (NYSE:WORK) and other workplace productivity tools. Teams is geared more for the enterprise level, but with many companies still contemplating the extent of their remote work plans, Microsoft looks to be a winner.

And the company is getting ready to launch a new version of its popular Xbox gaming console. That will pull in sales from the gaming community, which by the way has been red hot in this pandemic.

Microsoft is not without its headwinds. There is mounting evidence that traders are closing positions with the expectation that Microsoft will back off from its bid to buy TikTok. But that may work to the benefit of opportunistic investors. The stock is widely thought of as being near a top. Shaving a few dollars off the share price should make for a nice buy-on-the-dip opportunity.

About Microsoft
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. Its Productivity and Business Processes segment offers Office, Exchange, SharePoint, Microsoft Teams, Office 365 Security and Compliance, and Skype for Business, as well as related Client Access Licenses (CAL); Skype, Outlook.com, OneDrive, and LinkedIn; and Dynamics 365, a set of cloud-based and on-premises business solutions for small and medium businesses, organizations, and enterprise divisions.Read More 

Current Price: $286.50
Consensus Rating: Buy
Ratings Breakdown: 30 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $315.71 (10.2% Upside)

#4 - DocuSign (NASDAQ:DOCU)

DocuSign logo

Another emerging trend is remote document signing. There are certain trends that make you wonder why this was ever not the normal way of doing things. That’s the case with DocuSign (NASDAQ:DOCU). Many things like mortgage documents, lease forms, health forms, and more that often required a face-to-face meeting and several minutes of tedious signing can now be handled quickly, and more importantly remotely.

And the simple reality is that we’re not going backwards. Once you’ve used the technology, you realize how simple it is and you won’t see any reason to go back to the old way. And DocuSign is not just a trend that emerged since the novel coronavirus arrived. The current generations that will be leading DocuSign’s growth are looking to have a big social media presence while avoiding actual human contact as much as possible. That’s terrible for society. It’s great for DocuSign.

And don’t be too concerned about DocuSign not being profitable yet. The company’s sales grew by 14% in the last quarter. This didn’t yet factor in the effect of the novel coronavirus. The company is also generating positive free cash flow. Analysts are projecting the company’s profitability may exceed 58% annually over the next five years.

About DocuSign
DocuSign, Inc provides cloud based software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management.Read More 

Current Price: $301.18
Consensus Rating: Buy
Ratings Breakdown: 15 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $273.00 (9.4% Downside)

#5 - HCA Healthcare (NYSE:HCA)

HCA Healthcare logo

No matter what party wins the election, healthcare will remain a hot button topic for the country. And as a company that is a for-profit operate of healthcare facilities, HCA Healthcare (NYSE:HCA) is a solid agnostic choice.

To be fair, HCA stock is down over 10% for the year. However, the stock was hit disproportionately hard in the March selloff, dropping over 50%. From that low, the stock is up nearly 100%, and nearly 40% in the last month alone. The company benefits from having patients receiving care in hospital settings. That was obviously not taking place for much of the spring.

And while there has been some improvement, volume is not likely to return to anything approaching normal until the pandemic ends. But when it does, the company should benefit from patients who will be scheduling outpatient procedures that they’ve been putting off.

Bears will point out that the company’s positive earnings report in July was impacted by stimulus money. But HCA has been a solid long-term stock. Over the past five years, HCA has seen its revenue grow by 7% compounded annually. Core earnings growth has been even better at an 11% compound annual growth rate (CAGR). And going back to 2007, the company has posted a CAGR in core earnings of 16%.

About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.Read More 

Current Price: $247.90
Consensus Rating: Buy
Ratings Breakdown: 17 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $240.44 (3.0% Downside)

#6 - CVS Health (NYSE:CVS)

CVS Health logo

While other chains such as Rite-Aid (NYSE:RAD) are continuing to struggle, CVS Health (NYSE:CVS) looks like they’ve caught a bit of a tailwind. That is likely to remain in full effect as health and wellness will remain a major topic of discussion.

Like HCA, CVS stock is down over 10% for the year. But widening the lens to the last 12 months shows a stock that is up nearly 15%. And the stock is up over 20% since the pandemic began.

In the short term, CVS should get a lift from its Return Ready service. This will allow the company to open Covid-19 testing facilities in a workspace or college campus. It can also allow the company to perform valuable related services such as contact tracing or giving flu shots. And it’s not a leap of faith to imagine that CVS may be a partner in administering a vaccine should one become available.

From a macro level, CVS will not be hurt by the digital health movement. In fact, the company may be a beneficiary of customers becoming more comfortable using health care monitoring equipment at home.

About CVS Health
CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate/Other. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise.Read More 

Current Price: $83.06
Consensus Rating: Buy
Ratings Breakdown: 13 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $93.06 (12.0% Upside)

#7 - Smith & Wesson (NASDAQ:SWBI)

Smith & Wesson Brands logo

At the risk of depressing the audience, I would be remiss to not include a gun stock on this list. And with a gain of nearly 175% for the year, Smith & Wesson (NASDAQ:SWBI) fits the bill nicely.

Security has now moved beyond home security systems. Consumers, particularly those in major metropolitan cities, are paying attention to their personal security like never before. Ironically, this is no longer a partisan issue. It’s a safety issue.

What was once a category that was seen as a “Republican issue” that centered on a perceived lack of access has now become a personal safety issue. According to the Brookings Institute nearly three million more firearms have been purchased in the three months ending in June. And half of that increase was in June.

Not surprisingly SWBI stock is up nearly 175% for the year with virtually all of that gain occurring from the start of June until the present day. And while both Democrats and Republicans are purchasing guns, you can expect that the sector will receive increased attention as November draws closer.

About Smith & Wesson Brands
Smith & Wesson Brands, Inc designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles, and muzzleloaders; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, Performance Center, Thompson/Center Arms, and Gemtech brands.Read More 

Current Price: $24.23
Consensus Rating: Buy
Ratings Breakdown: 3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $28.38 (17.1% Upside)


There is a difference between trading and investing. Making trades can be exciting and fun. You just have to be right a lot more than you’re wrong. Investing is a bit more boring, but it can help you stay calm during volatile times like the kind investors experience in every election year.

While its true elections have consequences, one of those consequences doesn’t have to be a drop in your portfolio. There are many stocks that are unaffected by the outcome of an election. Many of these are blue-chip stocks that offer investors a dividend in exchange for growth.

But there are some stocks that are poised for growth no matter which party occupies the White House. And those are the stocks to get in on now. Some of these stocks are having good years. Others are plodding along. However, all of these stocks look poised for growth no matter what the outcome of the election is.

And that means you can enjoy whatever this holiday season brings without trying to read the tea leaves of a new administration.

7 Stocks That Still Have Upside For Investors to Buy

It can be fun to invest in some speculative stocks. But it should go without saying that those stocks shouldn’t make up the bulk of your portfolio. In fact, it’s important to find a few good stocks that make up the base of your portfolio. These are momentum stocks that are in a strong uptrend.

One way to find such stocks is to look at the most active stocks (or volume leaders). Shares of these companies are among the most traded or have the highest dollar volume of shares traded in a given trading day.

Any stock may crack this list from time to time (for example, when there’s new news about the company). However, stocks tend to find their way on this list consistently that bear watching. That’s because this list indicates that there is pressure among investors to buy or sell the stock. And that makes an investor’s decision very simple.

And that’s the reason we created this special presentation. The stocks on this list are among the most actively traded stocks on the market today. They also share a similar quality. They are coming off strong years in 2020 and seem to be showing some consolidation for another leg up.

View the "7 Stocks That Still Have Upside For Investors to Buy" Here.

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.